Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 2, 1997, Pages 977-984

  Machelska, Halina ^a   Łabuz, Dominika ^a   Przewłocki, Ryszard ^a   Przewłocka, Barbara ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 7 NITROINDAZOLE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; FORMALDEHYDE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OPIATE AGONIST; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; HINDLIMB; INTRATHECAL DRUG ADMINISTRATION; MALE; NONHUMAN; PAIN; PRESSURE; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; ENZYME INHIBITORS; FORMALDEHYDE; INJECTIONS, SPINAL; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PAIN; PYRROLIDINES; RATS; RATS, WISTAR; RECEPTORS, OPIOID; SPINAL CORD;

EID: 0030802505     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. AANONSEN, L. M. AND WILCOX, G. L.: Noeiceptive action of excitatory amino acids in the mouse: Effects of spinaly administered opioids, phencyclidine and sigma agonists. J. Pharmacol. Exp. Ther. 234: 9-19, 1987.
2. 5 enkephalin and morphine in the mouse. Neuropeptides 30: 219-223, 1996.
3. BLAND-WARD, P. A. AND MOORE, P. K.: 7-nitro indazole derivatives are potent inhibitors of brain, endothelium and inducible isoforms of nitric oxide synthase. Life Sci. 57: 131-135, 1995.
4. BREDT, D. S. AND SNYDER, S. H.: Nitric oxide, a novel neuronal messenger. Neuron 8: 3-11, 1992.
5. BRUHWYLER, J., CHLEIDE, E., LIEGEOIS, J. F. AND CARREER, F.: Nitric oxide: A new messenger in the brain. Neurosci. Biobehav. Rev. 17: 373-384, 1994.
6. BUCCAFUSCO, J. J., TERRY, JR. A. V. AND SHUSTER, L.: Spinal NMDA receptor-nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat. Brain Res. 679: 189-199, 1995.
7. G-nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ. Res. 72: 387-395, 1993.
8. CALCAGNETTI, D. J., HELMSTETTER, F. J. AND FANSELOW, M. S.: Analgesia produced by centrally administered DAGO, DPDPE and U50488H in the formalin test. Eur. J. Pharmacol. 153: 117-122, 1988.
9. CHAPMAN, V. AND DICKENSON, A. H.: The combination of NMDA antagonism and morphine produced profound antinociception in the rat dorsal horn. Brain Res. 573: 321-323, 1992.
10. CHAPMAN, V., HALEY, J. E. AND DICKENSON, A. H.: Electrophysiologic analysis of preemptive effects of spinal opioids on N-methyl-D-aspartate receptor-mediated events. Anesthesiology 81: 1429-1435, 1994.
11. COLLIN, E., MAUBORGNE, A., BOURGOIN, S., MANTELET, S., FERHAT, L., HAMON, M. AND CESSELIN F.: Kappa-/mu-receptor interactions in the opioid control of the in vivo release of substance P-like material from the rat spinal cord. Neuroscience 51: 347-355, 1992.
12. DE BIASI, S. AND RUSTIONI, A.: Glutamate and substance P coexist in primary afferents terminals in the superficial laminae of spinal cord. Proc. Natl. Acad. Sci. U.S.A. 85: 7820-7824, 1988.
13. DICKENSON, A. H. AND SULLIVAN, A. F.: Subcutaneous formalin-induced activity of dorsal horn neurones in the rat: differential response to an intrathecal opiate administered pre or post formalin. Pain 30: 349-360, 1987.
14. DRAY, A., LASZLO, U. AND DICKENSON, A.: Pharmacology of chronic pain. TIPS 15: 190-197, 1994.
15. DUARTE, I. D. G. AND FERREIRA, S. H.: The molecular mechanism of central antinociception induced by morphine or carbachol and the L-arginie-nitric oxide-cGMP pathway. Eur. J. Pharmacol 221: 171-174, 1992.
16. DUARTE, I. D. G., LORENZETTI, B. B. AND FERREIRA, S. H.: Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur. J. Pharmacol. 186: 289-293, 1990.
17. DUN, N. J., DUN, S. L., WU, S. Y., FORSTERMANN, U., SCHMIDT, H. H. H. W. AND TSENG, L. F.: Nitirc oxide synthase immunoreactivity in the rat, mouse, cat and squirrel monkey spinal cord. Neuroscience 54: 845-857, 1993.
18. FERREIRA, S. H., DUARTE, I. D. G. AND LORENZETTI, B. B.: The molecular mechanism of action of peripheral morphine analgesia: Stimulation of the cGMP system via nitric oxide release. Eur. J. Pharmacol. 201: 121-122, 1991.
19. FIALLOS-ESTRADA, C. E., KUMMER, W., MAYER, B., BRAVO, R., ZIMMERMANN, M. AND HERDEGEN, T.: Long-lasting increase of nitric oxide synthase immunoreactivity, NADPH-diaphorase reaction and c-Jun co-expression in rat dorsal root ganglion neurons following sciatic nerve transsection. Neurosci. Lett. 150: 169-173, 1993.
20. GARTHWAITE, J. AND BOULTON, C. L.: Nitric oxide signalling in the central nervous system. Annu. Rev. Physiol. 57: 683-706, 1995.
21. GARTHWAITE, J., CHARLES, S. L. AND CHESS-WILLIAMS, R.: Endothelium-derived relaxing factor release on activation of NMDA receptors suggest role as intercellular messenger in the brain. Nature 336: 385-388, 1988.
22. GARTHWAITE, J.: Glutamate, nitric oxide and cell-cell signalling in the nervous system. TINS 14: 60-67, 1991.
23. GARRY, M. G., RICHARDSON, J. D. AND HARGREAVES, K. M.: Sodium nitroprusside evokes the release of immunoreactive calcitonin gene-related peptide and substance P from dorsal horn slices via nitric oxide-dependent and nitric oxide-independent mechanisms. J. Neurosci. 14: 4329-4337, 1994.
24. HALEY, J. E., DICKENSON, A. H. AND SCHACHTER, M.: Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology 31: 251-258, 1992.
25. HERDEGEN, T., RUDIGER, S., MAYER, B., BRAVO, R. AND ZIMMERMANN, M.: Expression of nitric oxide synthase and colocalisation with Jun, Fos and Krox transcription factors in spinal cord neurons following noxious stimulation of the rat hindpaw. Molec. Brain Res. 22: 245-258, 1994.
26. IWAMOTO, E. T. AND MARION, L.: Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats. J. Pharmacol. Exp. Ther. 266: 329-338, 1993.
27. IWAMOTO, E. T. AND MARION, L.: Pharmacologic evidence that the spinal muscarinic analgesia is mediated by an L-arginine/nitric oxide/cyclic GMP cascade in rats. J. Pharmacol. Exp. Ther. 271: 601-608, 1994.
28. KANGRGA, I. AND RANDIĆ, M.: Outflow of endogenous aspartate and glutamate from the rat spinal dorsal horn in vitro by activation of low-and high-threshold primary afferent fibers. Modulation by μ-opioids. Brain Res. 553: 347-352, 1991.
29. KAWABATA, A., MANABE, S., MANABE, Y. AND TAKAGI, H.: Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: A dual role of peripherally formed NO in pain modulation. Br. J. Pharmacol. 112: 547-550, 1994.
30. KAWABATA, A., UMEDA, N. AND TAKAGI, H.: L-arginine exerts a dual role in nociceptive processing in the brain: Involvement of the kyotorphin-Met-enkephalin pathway and NO-cyclic GMP pathway. Br. J. Pharmacol. 109: 73-79, 1993.
31. KHACHATURIAN, H., SCHÄFER, M. K. H. AND LEWIS, M. E.: Anatomy and function of the endogenous opioid systems. In Handbook of Experimental Pharmacology. Opioids II, ed. by A. Herz, pp. 471-528, Springer-Verlag, New York, 1993.
32. KITTO, K. F., HALEY, J. E. AND WILCOX, G. L.: Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci. Lett. 148: 1-5, 1992.
33. KOLESNIKOV, Y. A., PICK, C. G. AND PASTERNAK, G. W.: NG-nitro-L-arginine prevents morphine tolerance. Eur. J. Pharmacol. 221: 399-400, 1992.
34. 125I]MK-801 binding decrease in rat spinal cord after unilateral hind paw inflammation. Neuroscience 68: 159-165, 1995.
35. LAM, M. M. D., HANLEY, D. F., TRAPP, B. D., SAITO, S., RAJA, S., DAWSON, T. M. AND YAMAGUCHI H.: Induction of spinal cord neuronal nitric oxide synthase (NOS) after formalin injection in the rat hind paw. Neurosci. Lett. 210: 201-204, 1996.
36. LEE, J.-H., WILCOX, G. L. AND BEITZ, A. J.: Nitric oxide mediates Fos expression in the spinal cord induced by mechanical noxious stimulation. NeuroReport 3: 841-844, 1992.
37. LEI, S. Z., PAN, Z-H., AGGARWAL, S. K., CHEN, H-S. V., HARTMAN, J., SUCHER, N. J. AND LIPTON, S. A.: Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 8: 1087-1099, 1992.
38. LIPTON, S. A., CHOI, Y-B., SUCHER, N. J., PAN, Z-H. AND STAMLER, J. S.: Redox state, NMDA receptors and NO-related species. TIPS 17: 186-187, 1996.
39. LUO, D., DAS, S. AND VINCENT, R. S.: Effects of methylene blue and LY83583 on neuronal nitric oxide synthase and NADPH-diaphorase. Eur. J. Pharmacol. Molec. Pharmacol. Sec. 290: 247-251, 1995.
40. MAJEED, N. H., PRZEWŁOCKA, B., MACHELSKA, H. AND PRZEWŁOCKI, R.: Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology 33: 189-192, 1994.
41. MALMBERG, A. B. AND YAKSH, T. L.: Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain 54: 291-300, 1993.
42. 2 using microdialysis in conscious rats. Br. J. Pharmacol. 114: 1069-1075, 1995.
43. MELLER, S. T. AND GEBHART, G. F.: Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52: 127-136, 1993.
44. MELLER, S. T., DYKSTRA, C. AND GEBHART, G. F.: Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-D-aspartate-produced facilitation of the nociceptive tail-flick reflex. Eur. J. Pharmacol. 214: 93-96, 1992.
45. MELLER, S. T., DYKSTRA, C. AND GEBHART, G. F.: Acute thermal hyperalgesia in the rat is produced by activation of N-methyl-D-aspartate receptors and protein kinase C and production of nitric oxide. Neuroscience 71: 2, 327.-335, 1996.
46. MILLAN, M. J.: K-opioid receptors and analgesia. TIPS 11: 70-76, 1990.
47. MILLAN, M. J., CZŁONKOWSKI, A., LIPKOWSKI, A. AND HERZ, A.: Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in additional to spinal sites of action. J. Pharmacol. Exp. Ther. 251: 1, 342.-351, 1989.
48. MILLAN, M. J.: Multiple opioid systems and chronic pain. In Handbook of Experimental Pharmacology, Opioids II, ed. by A. Herz, pp. 127-149, Springer-Verlag, New York, 1993.
49. G-nitro arginine methyl ester inhibits antinociceptive activity in the mouse. Br. J. Pharmacol. 102: 198-202, 1991.
50. MOORE, P. K., WALLACE, P., GAFFEN, Z., HART, S. L. AND BABBEDGE, R. C.: Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br. J. Pharmacol. 110: 219-224, 1993.
51. NORTH, R. A.: Opioid receptors and ion channels. In Neurobiology of opioids. ed. by O. F. X. Almeida and T. S. Shippenberg, pp. 141-150, Springer-Verlag, New York, 1991.
52. PING, L., TONG, C., EISENACH, J. C. AND FIGUEROA, J. P.: NMDA causes release of nitric oxide from rat spinal cord in vitro. Brain Res. 637: 287-291, 1994.
53. PORRECA, F. AND BURKS, T. F.: Supraspinal opioid receptors in antinociception. In Handbook of Experimental Pharmacology, Opioids II, ed. by A. Herz, pp. 21-44, Springer-Verlag, New York, 1993.
54. PORRO, C. A. AND CAVAZZUTI, M.: Spatial and temporal aspects of spinal cord and brainstem activation in the formalin pain model. Prog. Neurobiol. 41: 565-607, 1993.
55. PRZEWŁOCKA, B., LASON, W. AND PRZEWŁOCKI, R.: Time-dependent changes in the activity of opioid systems in the spinal cord of monoarthritic rats - a release and in situ hybridization study. Neuroscience 46: 209-216, 1992.
56. PRZEWŁOCKI, R., HAARMANN, I., NIKOLARAKIS, K., HERZ, A. AND H. 246 LT, V.: Prodynorphin gene expression in spinal cord is enhanced after traumatic injury in the rat. Mol. Brain Res. 4: 31-41, 1988.
57. PRZEWŁOCKI, R., MACHELSKA, H. AND PRZEWŁOCKA, B.: Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord. Life Sci. 53: PL 1-5, 1993.
58. PRZEWŁOCKI, R., SHEARMAN, G. T. AND HERZ, A.: Mixed opioid/nonopioid effects of synorphin and dynorphin releated peptides after their intrathecal injection in rats. Neuropeptides 3: 233-240, 1983.
59. SATOH, M. AND KURAISHI, Y.: Opioid interactions with other neuropeptides in the spinal cord: relevance to nociception. In Neurobiology of opioids, ed. by O. F. X. Almeida and T. S. Shippenberg, pp. 261-271, Springer-Verlag, New York, 1991.
60. SEMOS, M. L. AND HEADLEY, P. M.: The role of nitric oxide in spinal nocieptive reflexes in rats with neurogenic and non-neurogenic peripheral inflammation. Neuropharmacology 33: 1487-1497, 1994.
61. SHIBUTA, S., MASHIMO, T., OHARA, A., ZHANG, P. AND YOSHIYA, I.: Intracerebroventricular administration of a nitric oxide-releasing compound, NOC-18, produces thermal hyperalgesia in rats. Neurosci. Lett. 187: 103-106, 1995.
62. SOLODKIN, A., TRAUB, R. J. AND GEBHART, G. F.: Unilateral hindpaw inflammation produces a bilateral increase in NADPH-diaphorase histochemical staining in the rat lumbar spinal cord. Neuroscience 51: 495-499, 1992.
63. SORKIN, L. S.: NMDA evokes an L-NAME sensitive spinal release of glutamate and citrulline. NeuroReport 4: 479-482, 1993.
64. WALKER, J. M., MOIDES, H. C., COY, D. H., YOUNG, E. A., WATSON, S. J. AND AKIL, H.: Dynorphin (1-17): Lack of analgesic but evidence for non-opiate electrophysiological and motor effects. Life Sci. 31: 1821-1824, 1982.
65. WHEELER-ACETO, H., PORRECA, F. AND COWAN, A.: The rat paw formalin test: comparison of noxious agents. Pain 40: 229-238, 1990.
66. XU, J. Y. AND TSENG, L. F.: Increase of nitric oxide by L-arginine potentiates β-endorphin-but not μ, δ-, or κ-opioid agonist-induced antinociception in the mouse. Eur. J. Pharmacol. 236: 137-142, 1993.
67. XU, J. Y. AND TSENG, L. F.: Nitric oxide/cyclic guanosine monophosphate system in the spinal cord differentially modulates intracerbroventriculary administered morphine-and β-endorphin-induced antinociception in the mouse. J. Pharmacol. Exp. Ther. 274: 8-16, 1995.
68. YAKSH, T. L.: The spinal actions of opioids. In Handbook of Experimental Pharmacology, Opioids II, ed. by A. Herz, pp. 53-76, Springer-Verlag, New York, 1993.
69. YAKSH, T. L., DRIKSEN, R. AND HARTY, G. J.: Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat. Eur. J. Pharmacol. 117: 81-88, 1985.
70. YAKSH, T. L. AND RUDY, T. A.: Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17: 1031-1036, 1976.
71. YANG, S-T.: Role of nitric oxide in the maintenance of resting cerebral blood flow during chronic hypertension. Life Sci. 58: 1231-1238, 1996.
72. YOUNG, L. T., WOODS, C. M., WANG, J.-F. AND ASGHARI, V.: Nitric oxide donor SIN-1 mediated down-regulation of the G protein α-subunit in C6 glioma cells. Life Sci. 60: 1279-1285, 1997.